IASIS PHARMA successfully participated in the 21st Hellenic Conference for Helicobacter Pylori and Other Infections of the Peptic System that took place at the National Center for Scientific Research “Democritos”, 1-2 April 2016 organized by the Hellenic Society for the Study of H pylori. Congress invitees included distinguished gastroenterologists and other relevant specialties such as GPs, Infectious Diseases Specialists, Biopathologists from Greece and abroad.

IASIS PHARMA actively participated with a unique natural pharmaceutical product: the mastihatherapy caps. These 350 mg capsules, with active ingredient natural Chios Mastic Gum, work against functional dyspepsia. The interest of the medical community was high for this natural medicine with 2,500 years of documented history, with numerous reports over the past and scientific research that is ongoing until today. ΙASIS PHARMA is the only company that acquires pure Chios Mastic directly from the Chios Mastic Growers Association ensuring the quality and originality of the production of mastihatherapy caps that are available exclusively through pharmacies in a box of 30 or 90 capsules by pharma Q, a member of ΙΑSIS PHARMA group of companies.

During the round table discussion having as subject the challenges in the treatment of H pylori, the lecture of the specialized gastroenterologist-hepatologist, Dr. Hr. Zavos under the title: “Alternative treatments: Probiotics-Mastic-Antioxidants-Immunomodulators”, attracted a lot of attention among the congress participants. Dr. Zavos referred to the clinical experience along with his own personal experience for the use of Chios Mastic in capsule form for the treatment of H pylori as an adjunctive approach to the standard therapeutic scheme.